---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-092020"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2023-08-15T23:59:59+00:00"
generated_at: "2026-06-11T09:35:01.541675+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals lowers stockholder quorum requirement from majority to one-third

## Summary
- Board approved amendment reducing quorum from majority to one-third of outstanding voting shares.
- Amendment effective August 15, 2023, applies to all stockholder meetings and class votes.
- Change aims to facilitate conducting business at meetings by lowering the attendance threshold.

## SEC filing metadata
- accession: 0001104659-23-092020
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2023-08-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465923092020/0001104659-23-092020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465923092020/tm2323884d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-092020
- JSON: https://secwatch.observer/filing/0001104659-23-092020.json
- Plain text: https://secwatch.observer/filing/0001104659-23-092020.txt

## Key facts
- Governance Changes
  Petros Pharmaceuticals, Inc.: Amended Article III, Section 7 of the bylaws to reduce the stockholder quorum requirement from a majority to one-third of outstanding shares (effective 2023-08-15).
  - Change: bylaw amendment
  - Effective: 2023-08-15
  source text: On August 15, 2023, the board of directors of Petros Pharmaceuticals, Inc. (the “Company”) approved an Amendment (the “Amendment”) to the Company’s Amended and Restated By-laws (the “By-laws”), which became effective as of August 15, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815903/000110465923092020/0001104659-23-092020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
